Page 170 - GPD-4-1

Gene & Protein in Disease Clinical findings of RYR1 mutation

the alpha-1-subunit of the human dihydropyridine-sensitive activity profiles of type 1 ryanodinereceptor channels
L-type voltage-dependent calcium-channel receptor in carrying malignant hyperthermia and central coredisease
skeletal muscle. Am J Hum Genet. 1997;60:1316-1325. mutations in the amino-terminal region. PLoS One.
doi: 10.1086/515454 2015;10(6):e0130606.
15. Avila G, O’Connell KM, Dirksen RT. The pore region of the doi: 10.1371/journal.pone.0130606
skeletal muscle ryanodine receptor is a primary locus for 18. Harikrishna GV, Padmanabha H, Polavarapu K, et al.
excitation-contraction uncoupling in central core disease. Phenotype-genotype correlation of a cohort of patients with
J Gen Physiol. 2003;121(4):277-286. congenital myopathy: A single centre experience from India.
doi: 10.1085/jgp.200308791 J Neuromuscul Dis. 2024;11(5):935-957.
16. Murayama T, Kurebayashi N, Ogawa H, et al. Genotype- doi: 10.3233/JND-230021
phenotype correlations of malignant hyperthermia and 19. Elbaz M, Ruiz A, Bachmann C, et al. Quantitative
central core disease mutations in the central region of the RYR1 reduction and loss of calcium sensitivity of
RYR1 channel. Hum Mutat. 2016;37(11):1231-1241. RYR1Q1970fsX16+A4329D cause cores and loss of muscle
doi: 10.1002/humu.23072 strength. Hum Mol Genet. 2019;28(18):2987-2999.
17. Murayama T, Kurebayashi N, Yamazawa T, et al. Divergent doi: 10.1093/hmg/ddz092

Volume 4 Issue 1 (2025) 6 doi: 10.36922/gpd.4748